Evidence map›Paper›PMID 31707427›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2020

Additional information on "Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for

René Raavé, Gerwin Sandker, Pierre Adumeau, Christian Borch Jacobsen, Floriane Mangin, Michel Meyer, Mathieu Moreau, Claire Bernhard, Laurène Da Costa, Adrien Dubois and 7 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

René RaavéDepartment of Radiology and Nuclear Medicine, Radboud Institute for Molecular Life Sciences, Radboud UMC, Nijmegen, The Netherlands.
Gerwin SandkerDepartment of Radiology and Nuclear Medicine, Radboud Institute for Molecular Life Sciences, Radboud UMC, Nijmegen, The Netherlands.
Pierre AdumeauInstitut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 avenue A. Savary, 21078, Dijon Cedex, France.
Christian Borch JacobsenGlobal Research Technologies, Novo Nordisk A/S, Novo Nordisk Park, DK-2760, Måløv, Denmark.
Floriane ManginInstitut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 avenue A. Savary, 21078, Dijon Cedex, France.
Michel MeyerInstitut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 avenue A. Savary, 21078, Dijon Cedex, France.
Mathieu MoreauInstitut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 avenue A. Savary, 21078, Dijon Cedex, France.
Claire BernhardInstitut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 avenue A. Savary, 21078, Dijon Cedex, France.
Laurène Da CostaInstitut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 avenue A. Savary, 21078, Dijon Cedex, France.
Adrien DuboisInstitut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 avenue A. Savary, 21078, Dijon Cedex, France.
Victor GoncalvesInstitut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 avenue A. Savary, 21078, Dijon Cedex, France.
Magnus GustafssonGlobal Research Technologies, Novo Nordisk A/S, Novo Nordisk Park, DK-2760, Måløv, Denmark.
Mark RijpkemaDepartment of Radiology and Nuclear Medicine, Radboud Institute for Molecular Life Sciences, Radboud UMC, Nijmegen, The Netherlands.
Otto BoermanDepartment of Radiology and Nuclear Medicine, Radboud Institute for Molecular Life Sciences, Radboud UMC, Nijmegen, The Netherlands.
Jean-Claude ChambronInstitut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 avenue A. Savary, 21078, Dijon Cedex, France. jcchambron@unistra.fr.
Sandra HeskampDepartment of Radiology and Nuclear Medicine, Radboud Institute for Molecular Life Sciences, Radboud UMC, Nijmegen, The Netherlands. Sandra.Heskamp@radboudumc.nl.
Franck DenatInstitut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 avenue A. Savary, 21078, Dijon Cedex, France. franck.denat@u-bourgogne.fr.ORCID 0000-0002-9652-4006

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

RadioisotopesZirconiumRadiopharmaceuticalsRadioisotopesRadiopharmaceuticalsZirconiumZirconium-89

Identifiers

PMID31707427
PMCPMC6974525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.